Fundamentals

Valuation

Metric	Q1	Q2	Δ in %
EV/EBITDA	-54.24	21.17	46.26
Graham Fair Price	40.60	14.69	10.45
PEG	-29.90	< 0.005	< 0.005
Price/Book	-16.18	0.03	0.04
Price/Cash Flow	58.09	-0.79	-1.89
Prices/Earnings	58.09	-0.15	-0.36
Price/Sales	-58.09	0.38	0.90
Price/FCF	58.09	-0.79	-1.89
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q1	Q2	Δ in %
Gross Profit Margin	-11.61	0.82	0.92
Operating Margin	0.00	0.68	0.68
ROA	-100.00	-0.02	< 0.005
ROE	-0.03	-0.06	-100.00
ROIC	0.01	0.02	89.19
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q1	Q2	Δ in %
Debt QOQ	< 0.005	0.05	-93.24
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-0.56	1.00	79.10
EPS QOQ	-1.67	-1.00	40.22
FCF QOQ	0.63	-1.00	59.00
Revenue QOQ	-0.55	1.00	83.30
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q1	Q2	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	13743.95	2836.17	-79.36
Days Sales Outstanding (DSO)	120.56	323.86	168.64
Inventory Turnover	< 0.005	0.03	384.60
Debt/Capitalization	0.62	0.61	-0.12
Quick Ratio	0.61	1.32	114.98
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q1	Q2	Δ in %
Book Value	13.11	13.04	-0.58
Cash	4.31	6.65	54.19
Capex	< 0.005	-0.02	-98.84
Free Cash Flow	-0.29	-0.57	-98.84
Revenue	0.60	1.19	98.84
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q1	Q2	Δ in %
Current Ratio	1.81	1.81	0.00
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	45.02	20.69	-54.05
Naive Interpretation	Member

06 - Financial Health · Weak

Rating